Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
LEHI, Utah, September 18, 2026--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, has been named the No. 1 Leader in G2's Fall 2026 Grid® Report for Patient Relationship Management (PRM) software, earning the highest satisfaction score and largest market presence of any product in the category. In G2's verified reviews, 94% of users rated Weave 4 or 5 stars, and 96% said the product is headed in the right direction.
The latest update for Weave Communications centres on a revised fair value estimate that moves from US$8.75 to US$7.81 per share. This adjustment sits alongside analyst discussion of the agreed US$7.40 cash acquisition price and earlier price targets in the US$8 to US$9 range, with views split between deal driven outcomes and potential upside if the company remains independent. As you read on, you will see how these shifting price targets fit into the broader narrative and what signals to...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.